NCT06170515View on ClinicalTrials.gov

BGM and HbA1c POC Device Evaluation

NARecruitingINTERVENTIONAL
Enrollment

910

Participants

Timeline

Start Date

April 3, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Diabetes
Interventions
DIAGNOSTIC_TEST

CareSens N-Eco (i-Sens), • CareSens N-Premier (i-Sens), CodeFree (SD Biosensor), GlucoNavii GDH (SD Biosensor)

BGM Test

DIAGNOSTIC_TEST

Affinion (Abbott), HbA1c 501 (HemoCue), A1Care (iSens), DCA Vantage (Siemens)

HbA1c Test

Trial Locations (3)

12253

RECRUITING

Sihanouk Hospital Centre of Hope, Phnom Penh

111311

NOT_YET_RECRUITING

Asociación Colombiana de Diabetes, Bogotá

Unknown

RECRUITING

Lagos University Teaching Hospital, Lagos

All Listed Sponsors
lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER